Nelfinavir Mesylate

Overview

Nelfinavir Mesylate (AG 1343 Mesylate) is a potent and orally bioavailable HIV-1 protease inhibitor ( K i =2 nM) for HIV infection . Nelfinavir Mesylate (AG 1343 Mesylate) is a broad-spectrum, anticancer agent.

Application

Products | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Viral Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HIV Protease | Products > Signaling Pathways > HIV

Product Information

• Catalog No.: HY-15287A
• CAS No.: 159989-65-8
• Molecular Formula: C33H49N3O7S2
• Molecular Weight: 663.89
• Purity: 99.04%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Solubility: ≥ 5 mg/mL (7.53 mM); Clear solution
• Availability: In-stock

Source

Original product source